✦ LIBER ✦

Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: The INtegrilin plus STenting to Avoid myocardial Necrosis Trial

✍ Scribed by Giuseppe Biondi-Zoccai; Marco Valgimigli; Massimo Margheri; Antonio Marzocchi; Corrado Lettieri; Amerigo Stabile; A. Sonia Petronio; Giorgio Binetti; Leonardo Bolognese; Pietro Bellone; Gennaro Sardella; Marco Contarini; Imad Sheiban; Sebastiano Marra; Federico Piscione; Francesco Romeo; Antonio Colombo; Giuseppe Sangiorgi

Book ID: 116192738
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 391 KB
Volume: 163
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2012.02.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB